Women’s Health Daignostics Industry
Description
Wiseguyreports.Com Adds “Global Women’s Health Daignostics Market – by Type, Application, End Use, Region – Market Size, Demand Forecasts, Company Profiles, Industry Trends and Updates (2020-2025)” To Its Research Database
In the present-day scenario, the world has come to terms with the fact that both men and women are equally an integral part of the society. According to the recent statistics, women account for 49% of the population and hence their well-being plays a key role in the development of the society. The growth in the number of women prone to diseases is an area of concerns and is driving this market.
Demand Scenario
The global women’s health diagnostics market was USD 24.52 billion in 2018 and is estimated to reach USD 41.03 billion by 2025 at a CAGR of 7.63% during the forecast period
Growth by Region
North America will be the fastest growing market during the forecasted period. After North America, Europe, Asia Pacific, Latin America, Middle East and Africa are likely to follow.
Company Profiles
Abbott Laboratories
F. Hoffmann-La Roche
Hologic
Siemens
GE Healthcare
MedGyn Products
PerkinElmer
Thermo Fisher Scientific
Carestream Health
Becton
Cardinal Health
Becton
C. R. Bard Inc
Alere Inc
Quest Diagnostics
Cook Medical Inc
Dickinson & Company
bioMerieux SA
Koninklijke Philips N.V.
Mindray
Sysmex
Urit Medical
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/4353130-global-women-s-health-daignostics-market-by-type
Drivers vs. Constraints
The factors leading to the growth of the market are poor diet and unhealthy lifestyle the women are exposed to. Due to this reason, there have been rapid increase in the hormonal and non-hormonal diseases affecting the female population. Some of the most commonly diagnosed ones include breast cancer, cervical cancer, infertility, PCOS and others. The advancement in the medical facility and increasing awareness among the women are major causes which will drive this industry
Industry Structure and Updates
In May 2018, Myriad Genetics signed definitive agreement to acquire Counsyl to create premier Women’s Health Business Unit in High growth genetic testing market
In May 2018, Ava, the maker of a fertility tracking device raised 30 Million dollars to spend on Women’s Health Industry
Table of Content
1. Research Methodology
2. Executive Summary
3. Market Overview
3.1. Definition
3.2. Industry Value Chain Analysis
3.3. Porter’s 5 Forces
3.4. Regulations
4. Market Dynamics
4.1. Introduction
4.2. Drivers
4.3. Constraints
4.4. Trends
5. Global Women’s Health Diagnostics Market Segmentation, Forecasts and Trends – by Type
5.1. Diagnostic Devices
5.2. Diagnostic Tests
5.3. Accessory & Consumables
6. Global Women’s Health Diagnostics Market Segmentation, Forecasts and Trends – by Application
6.1. Biopsy Devices
6.2. Imaging & Monitoring System
6.3. Breast Cancer Testing
6.4. Cervical Cancer Testing
6.5. Pregnancy & Ovulation Testing
6.6. Ovarian Cancer
6.7. Prenatal Genetic Screening & Carrier Testing
7. Global Women’s Health Diagnostics Market Segmentation, Forecasts and Trends – by End Use
7.1. Hospitals and Clinics
7.2. Diagnostic & Imaging Centres
7.3. Home Care
7.4. Medical Device Manufacturers
7.5. Research Institutions
7.6. Others
8. Global Women’s Health Diagnostics Market Segmentation, Forecasts and Trends – by Region
8.1. North America
8.1.1. U.S.
8.1.2. Canada
8.1.3. Mexico
8.2. Europe
8.2.1. UK
8.2.2. France
8.2.3. Germany
8.2.4. Italy
8.2.5. Others
8.3. Asia Pacific
8.3.1. India
8.3.2. China
8.3.3. Japan
8.3.4. Australia
8.3.5. Others
8.4. South America
8.4.1. Brazil
8.4.2. Argentina
8.4.3. Others
8.5. Middle East and Africa
8.5.1. South Africa
8.5.2. UAE
8.5.3. Saudi Arabia
8.5.4. Egypt
8.5.5. Others
9. Competitive Intelligence
11. Investment Opportunities
Continued…
Leave a Query @ https://www.wiseguyreports.com/enquiry/4353130-global-women-s-health-daignostics-market-by-type
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
